13 articles
USV Pvt Ltd will acquire the JALRA trademark from Novartis for 200 crores as the patent for Vildagliptin expires. The bulletin also discusses major updates in domain name…
The Supreme Court’s Novartis judgment clarified Section 3d and its application to pharmaceutical patents in India. It emphasised the need for enhanced therapeutic efficacy and outlined critical standards…
The latest patent news analyses trends in Indian patent filings and grants, key court orders, and major patent settlements. It includes updates on the voting machine patent, Novartis's…